Publications

Validated by research conducted by ExpreS2ion and our partners, including AdaptVac Aps, the ExpreS2 platform technology of ExpreS2ion stands as a testament to our innovative approach. Each publication featured here underscores the crucial proof-of-concept for our technology and the potential of the vaccine candidates it facilitates.


EXP_Icon_Malaria

King et al.
Cell (2024)